Work

Editorial: Cellular Senescence: Causes, Consequences and Therapeutic Opportunities

Year: 2022
Type: editorial
Abstract: Once regarded as a tissue culture phenomenon, cellular senescence has long come of age.It is one of the hallmarks of aging and widely accepted as an important driver of the progression of age-related degenerative pathologies such as cardiovascular disease, neurodegenerative disease and type 2 diabetes (Muñoz-Espin and Serrano, 2014;Franceschi et al., 2018).The concept of reducing the burden of senescent cells or suppressing senescence-associate secretory phenotype (SASP) to delay age-related changes, improve tissue functions and subsequently increase health and life span were introduced and proven by many studies (Xu et al., 2015;Zhu et al., 2015Zhu et al., , 2017;;Chang et al., 2016;Fuhrmann-Stroissnigg et al., 2017).These ground-breaking findings underpin the rapidly expanding field of senotherapeutics to identify drugs that can eliminate senescent cells (senolytics) or suppress SASP (senomorphics) as a novel pharmacological approach to concurrently treat age-related multimorbidities.In this Research Topic, we showcase both fundamental and translational advances in our understanding of cellular senescence, which will form the basis of future therapies for age-related degenerative changes.Schroth et al. discussed how senescent cell accumulation as a result of defective innate and adaptive immune responses leads to the progression of chronic kidney diseases (CKD), rationalizing the use of various immunomodulation approaches to enhance immunosurveillance and clearance of senescent cells for CKD treatment.Currently, strategies enhancing the cytotoxic activity of NK cells against senescent cells, activating the antibody-dependent cell-mediated cytotoxicity (ADCC) and dampening SASP-derived inflammatory milieu by targeting NF-κB and c/EBPβ transcriptional activities are being studied intensively (Paez-Ribes et al., 2019).Wilkinson and Hardman offered their new insight on the physiological and pathophysiological roles of cellular senescence in diabetic would healing.While short-lived tissue senescence is essential for effective repair, sustained tissue senescence involving the senescence-linked chemokine receptor, CXCR2, impairs diabetic wound healing.The blockage of CXCR2 promoted wound repair, thus, bolstering the notion of suppressing SASP for chronic wound healing treatment.Indeed, metformin, an effective anti-diabetic drug, via its SASP suppression activity has been shown to accelerate wound healing (Qing et al., 2019).Ramasamy et al. in their review on chondrocyte senescence and cartilage degeneration, highlighted the use of senolytics such as FOXO4-p53-interfering peptides or dasatinib/ quercetin to selectively eliminate senescent cells during the in vitro expansion of cells used for autologous chondrocyte implantation (ACI).ACI is a targeted approach used to treat articular cartilage injuries and prevent the onset of post-traumatic osteoarthritis.Although effective in eliminating senescent cells within the expanded cell population and thus, increasing cell differentiation efficiency, whether these drugs could produce greater repair potential and promote cartilage repair clinically warrants further investigations (Huang et al., 2021).Similarly,
Language: English
Subfield: Cell Biology
Open Access status: gold
Estimated APC paid: $2,950
OpenAlex ID: W4226071383
Cites: 15
Cited by: 1
Related to: 10